Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Urol Oncol. 2019 Feb 13;37(6):352.e19–352.e24. doi: 10.1016/j.urolonc.2019.01.029

Fig. 1A.

Fig. 1A.

Effect of prior definitive therapy for localized prostate cancer on time to mCRPC for men with newly diagnosed mHSPC. mCRPC = metastatic castration-resistant prostate cancer; mHSPC = metastatic hormone sensitive prostate cancer.